• Overview of changes in AMS with the rollout of electronic health records
• Describe emerging models of care and workflows in antimicrobial surveillance and stewardship.
• Discuss clinical analytics and reporting opportunities
• Discuss clinical decision support opportunities

In the era of data connectivity, systems are required to have common terminology to allow data transfer and improve reporting and benchmarking capabilities. To assist with this, we have created a system for managing coded lists of medications and indications. This presentation will discuss:

• the theory and need for interoperability;
• the development and practical application of the UIL; and implementation of the UIL within clinical applications.

• Our QCH AMS Digital journey thus far (partnerships, engagement, design and development of digital dashboard and challenges)
• A day with digital AMS (IV to oral switch, Restricted antimicrobial review and Surgical antimicrobial stewardship)
• Implementing a digital AMS platform in a UK children’s hospital
• Maximising data for audit, reporting and research

(CHIRPs = Children’s Health Intelligence Reporting Portals)

• Delivering health services to Australians living in rural and remote Australia
• eMedicines Management and eMedical Records as enablers
• Linking data sets across systems to drive quality improvement
• Lessons learnt

• Using Benefits Realisation Management principles to develop evaluation frameworks to assess EMM project benefits
• Applying Evaluation Frameworks in a real-world setting: Presentation of pre and post data on Metro North Hospital and Health Services roll-out of Automated Dispensing Cabinets, pharmacy dispensing robotics and Electronic Prescribing and Medication Administration systems.
• Why EMM programs should place value on using best practice research methodology to evaluate and optimise EMM project outcomes

• Results of a staff tracking exercise pre and post implementation of an EMM system at a South Australian hospital
• Are nurses now “caring for the computer”?
• Some things are harder, some are easier… but what is the overall impact?
• The challenge of standardising practice in a non-standard environment

• Supporting current eMM users – challenges in resourcing and distance.
• Supporting eMM deployment – how the HNELHD model has changed over the last 3 years.
• How has the introduction of an eMM solution challenged technical and clinical service provision?

This new session is designed to provide a brief glimpse into what is happening at different sites across the country. What has been trialed, what has worked and what has failed. Speakers will be asked to give a 5-10 minute presentation including details on the scope of eMeds at their site, are any medications still on paper? Do they do complex meds? Barcode scanning? Clinical decision support? Closed loop medication management?